ISCT-AABB Quality Agreement Template



ISCT-AABB Quality Agreement Template

ISCT and AABB are pleased to offer our members access to the jointly created ISCT-AABB interpretive tool to assist with drafting a Quality Agreement that may be used with external entities that perform critical services including procurement, manufacturing, testing and administration of a cell/tissue product.

The Quality Agreement Template outlines scope of work, deliverables, timelines to clearly define expectations between parties and responsibilities regarding Quality Assurance, Quality Control and Quality Risk Management.

Available to ISCT and AABB Members Only
Access via your ISCT Membership below

In the field of Biotherapy partnerships, agreements with external entities to perform critical services have become more commonplace.  These services can include procurement, manufacturing, testing and administration of a cell/tissue product. Such relationships are defined through the use of a Service Agreement and a Quality Agreement. Service contracts typically outline the scope of work, deliverables, timelines, budgets, and business and legal liabilities. Quality Agreements identify and describe key quality and regulatory responsibilities between the client and the service provider.

The intent of a Quality Agreement is to have clearly defined expectations between parties with emphasis on each party having a sense of ownership through mutually agreed upon language and activities. At a minimum, the Quality Assurance personnel of all entities should have input into drafting the Quality Agreement, with feedback from the respective stakeholders including but not limited to: sponsor, investigator, administration site, and procurement, processing, manufacturing facility(ies).

How To Access:

The Quality Agreement Template is available to current ISCT and AABB members only.

Please log into your ISCT member account to access the document below. 

Not an ISCT Member?  Join/Renew Now.

ISCT-AABB Quality Agreement Project Team

Diane Kadidlo, MT(ASCP), SBB
Project Co-Leader
Facility Director, Molecular and Cellular Therapeutics
University of Minnesota
St. Paul, MN

Sufira Kiran, BS, CQA, MLS
Associate Director of Quality Assurance Research
Manufacturing at UTHealth Science Center
University of Texas Health Science Center
Houston, TX

Aisha Khan, PhD, MBA
Executive Director Of Clinical Research & Laboratory Operations 
University of Miami
Miami, FL

Suzanne Dworsky, BS,CABP(H),MBA, MT(ASCP)  
Medicine Department Administrator, Stem Cell Transplantation and Cellular Therapy
MD Anderson Cancer Center
Houston, TX

Diana Nordling
Director Quality Assurance Regulatory Affairs, Transplant Services/Cell Therapy 
Hoxworth Blood Center
Cincinnati, OH

Brenda Alder, MS, MT(ASCP)SBB, CABP(H)
Cell Therapy Transplant and Tissue Bank QA and Regulatory Manager, Northside Hospital
Peachtree Corners, GA

Mary Grable McLeod, MLS(ASCP)CM SBBCM, SSGB (ASQ), CABP(H)
Project Co-Leader
Quality Manager – Blood and Marrow Transplant Cellular Therapy Facility
Stanford, CA
 
Jelena Holovati, PhD
Associate Professor, Director, Edmonton Stem Cell Manufacturing Program, Canadian Blood Services
Department of Laboratory Medicine & Pathology
Division of Medical Laboratory Science
University of Alberta
Alberta, Canada
 
Aleksandra Babic
Senior Manager Quality Assurance
Site Qualification and Regional Operation Quality ACE and International
Kite Pharma a Gilead Company
CapitaSpring, Singapore
Netherlands
 
William Shingler, PhD, MBA
Senior Director, Patient and Cell Management
Autolus
London, UK